Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)

Clinical trial NCT07482176 · RECRUITING

Trial details

NCT number: NCT07482176
Sponsor: Adverum Biotechnologies, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Neovascular Age-Related Macular Degeneration (nAMD)Wet AMD

Start date: 2026-03-16
Primary completion: 2027-11-15
Enrollment: 284

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.